b.well Connected Health and myTomorrows Partner to Improve Clinical Trial Access
b.well Connected Health and myTomorrows have announced a partnership to improve how patients are connected to clinical trials, according to a press release.
The collaboration combines b.well's platform, which unifies health data from nearly 2.4 million providers, over 330 health plans, multiple state health information exchanges, laboratories, pharmacies, and hundreds of wearables and health sensors, with myTomorrows' AI technology for clinical trial pre-screening and matching.
By integrating these systems, the companies aim to help pharmaceutical sponsors and trial sites identify and enroll eligible patients more efficiently. The joint approach is designed to reduce patient burden while accelerating access to relevant clinical trial opportunities earlier in the care process.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Oct 16 BOC Group Adds AI Assistant to ADOIT 21 Oct 16 Huawei Brings Upgraded Stellar Network Solution to Europe Oct 16 Element to Manage Waymo's Toronto Fleet for 2028 Launch Oct 16 CTM and Huawei Plan AI Network Security Upgrades in Macao Oct 16 Huawei and 14 partners form Global AI CITY allianceMore from Life Sciences
Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice Operations Oct 15 Study Tracks 270 Million Clinical AI Queries on OpenEvidence Oct 15 OpenAI Offers US University Labs Free GPT-Rosalind AccessLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Verana Health and Bitfount Detail AI Prescreening for Eye Trials
TRI Launches TRIAL.OS for Clinical Trial Management
Amigo Rebrands as Concurrence
Lunit and Discovery Life Sciences Partner on AI Tissue Analysis
POMDOCTOR Outlines Predictive Healthcare Strategy
Daily AI Brief: the AI news that matters, in your inbox.